Application no. and date | 10174983.6 (espacenet) (Federated) (European Patent Register), 20020218 | Patent/reg. no. and date | DK/EP 2269603, 20150520 | Publication date | 20110105 | Priority no. and date | GB 0104072, 20010219, GB 0124957, 20011017 | EP pub. no. and date |
EP 2269603 20110105 | Effective date | | Applicant/owner | Novartis Pharma AG, Lichtstrasse 35
4056 Basel, CH, Novartis International Pharmaceutical AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | V134193 | Inventor | O'Reilly, Terence, Drahtzugstrasse 51
4057 Basel, CH, Lane, Heidi, Jakobsweg 22
4105 Biel-Benken, CH, Wood, Jeanette Marjorie, In den Kleematten 18
4105 Biel-Benken BL, CH | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/337 (2006.01) , A61K 31/436 (2006.01) , A61K 31/475 (2006.01) , A61K 31/502 (2006.01) , A61K 31/555 (2006.01) , A61K 31/5685 (2006.01) , A61K 31/704 (2006.01) , A61K 31/7068 (2006.01) , A61K 33/24 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | Title | BEHANDLING AF BRYSTTUMORER MED ET RAPAMYCINDERIVAT I KOMBINATION MED
EXEMESTAN | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2015 00058 | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|